RT @Yuz6Yusof: No clear winner here. The majority would use #IL23 inhibitors as either 2nd or 3rd line bDMARDs and for #
Tweet Content
No clear winner here. The majority would use #IL23 inhibitors as either 2nd or 3rd line bDMARDs and for #psoriaticarthritis with severe #psoriasis. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/b8wzaRVTqw
Show on Archive Page
On
Display in Search Results
On
PDQ
Off